| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/21/2001 | WO1997043901A9 IceA GENE AND RELATED METHODS |
| 06/21/2001 | DE19960705A1 Verfahren und Vorrichtung zur Herstellung eines autologen Immunisierungsimpfstoffes gegen Krebserkrankungen (Tumorvakzine) Method and apparatus for producing an autologous vaccine immunization against cancer (cancer vaccines) |
| 06/21/2001 | CA2406678A1 Method of enhancing immune responses to herpes simplex virus vaccine |
| 06/21/2001 | CA2396503A1 Stabilizing diluent for polypeptides and antigens |
| 06/21/2001 | CA2394576A1 Betaglycan as an inhibin receptor and uses thereof |
| 06/21/2001 | CA2394574A1 Dna encoding a novel rg1 polypeptide |
| 06/21/2001 | CA2394536A1 Tnfr/opg-like molecules and uses thereof |
| 06/21/2001 | CA2394466A1 Polypeptides and nucleic acids encoding same |
| 06/21/2001 | CA2394445A1 Antigen delivery |
| 06/21/2001 | CA2394431A1 Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists |
| 06/21/2001 | CA2394357A1 Modified leukotoxin gene and protein |
| 06/21/2001 | CA2393861A1 Polynucleotide vaccines expressing codon optimized hiv-1 nef and modified hiv-1 nef |
| 06/21/2001 | CA2393371A1 Use of inactivated immunosuppressive or angiogenic immunogenic proteins for producing secretory iga's |
| 06/21/2001 | CA2393292A1 Brain specific binding members |
| 06/21/2001 | CA2392766A1 Novel helicobacter pylori-binding substances and use thereof |
| 06/21/2001 | CA2390689A1 Human lyases and associated proteins |
| 06/21/2001 | CA2390662A1 Bcl-g polypeptides, encoding nucleic acids and methods of use |
| 06/21/2001 | CA2328820A1 Coccidiosis vaccines |
| 06/20/2001 | EP1108787A2 Production of vaccines |
| 06/20/2001 | EP1108738A2 Immunostimulating carrier for vaccines |
| 06/20/2001 | EP1108725A1 Novel polypeptide |
| 06/20/2001 | EP1108436A1 Preventives/remedies for arteriosclerosis and post-ptca reangiostenosis |
| 06/20/2001 | EP1108433A2 Combination vaccine for enhancing immunity against brucellosis |
| 06/20/2001 | EP1108046A1 Guanylate binding protein (gbp-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation |
| 06/20/2001 | EP1108038A1 Superoxide dismutase as a vaccine antigen |
| 06/20/2001 | EP1108036A1 Dengue viruses that are replication defective in mosquitos for use as vaccines |
| 06/20/2001 | EP1108035A2 Treatment of cervical cancer |
| 06/20/2001 | EP1108034A2 Attenuated salmonella spi2 mutants as antigen carriers |
| 06/20/2001 | EP1108033A2 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 06/20/2001 | EP1108028A2 Dna cancer vaccine and methods for its use |
| 06/20/2001 | EP1108025A2 Phelix: a testis-specific protein expressed in cancer |
| 06/20/2001 | EP1108024A1 Lim domain protein homolog |
| 06/20/2001 | EP1108023A1 Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor |
| 06/20/2001 | EP1108019A2 Protein transport-associated molecules |
| 06/20/2001 | EP1108017A2 G-motif oligonucleotides and uses thereof |
| 06/20/2001 | EP1108014A1 $i(EHRLICHIA CANIS) 120-KDA IMMUNODOMINANT ANTIGENIC PROTEIN AND GENE |
| 06/20/2001 | EP1107996A1 HUMAN ANTI-FACTOR IX/IXa ANTIBODIES |
| 06/20/2001 | EP1107995A2 Bifunctional antibodies and their use in targeting anti-tumour agents |
| 06/20/2001 | EP1107993A1 Human monoclonal antibodies directed against the islet cell antigen ia-2 |
| 06/20/2001 | EP1107991A1 AN ANTI-CYANOVIRIN ANTIBODY WITH AN INTERNAL IMAGE OF gp120, A METHOD OF USE THEREOF, AND A METHOD OF USING A CYANOVIRIN TO INDUCE AN IMMUNE RESPONSE TO gp120 |
| 06/20/2001 | EP1107990A1 High-affinity antibodies |
| 06/20/2001 | EP1107989A2 Expression and export of angiostatin and endostatin as immunofusins |
| 06/20/2001 | EP1107986A1 Protein domains in the hepatic glycogen-targeting subunit of protein phosphatase 1 and methods of making and using the same |
| 06/20/2001 | EP1107977A1 Ratc |
| 06/20/2001 | EP1107959A2 Quinazoline derivatives as medicaments |
| 06/20/2001 | EP1107798A1 A novel method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 06/20/2001 | EP1107796A2 Cells expressing immunoregulatory molecules and uses therefor |
| 06/20/2001 | EP1107790A1 Targeting of molecules to large vessel endothelium using epcr |
| 06/20/2001 | EP1107789A1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage |
| 06/20/2001 | EP1107788A1 Scrp-5: secreted cysteine rich protein-5 |
| 06/20/2001 | EP1107787A2 Salmonella typhi vaccine compositions |
| 06/20/2001 | EP1107786A2 Recombinant subunit vaccine against flaviviral infection |
| 06/20/2001 | EP1107785A1 Method of dna vaccination |
| 06/20/2001 | EP1107784A2 Activation and protection of t-cells (cd4?+ and cd8?+ ) using an h 2? receptor agonist and other t-cell activating agents |
| 06/20/2001 | EP1107783A1 Method for inducing a cell-mediated immune response and parenteral vaccine formulations therefor |
| 06/20/2001 | EP1107782A1 Oral vaccine compositions |
| 06/20/2001 | EP1107779A2 Medicaments for manipulating t-cell immune response |
| 06/20/2001 | EP1107770A2 Neural retinal cells and retinal pigment epithelium cells and their use in treatment of retinal disorders |
| 06/20/2001 | EP1107769A2 Method for inducing a donor tolerance in the human body |
| 06/20/2001 | EP1107736A1 Microparticulate composition |
| 06/20/2001 | EP1107702A1 Ultrasonic enhancement of drug injection |
| 06/20/2001 | CN1300367A Methods and compositions for diagnosis of rheumatoid arthritis |
| 06/20/2001 | CN1300295A Hybrid protein for inhibiting the deatanulation of mastocytes and the use thereof |
| 06/20/2001 | CN1300294A Frameshift mutants of beta-amyloid precursor protein and ubiquitin-B and their use |
| 06/20/2001 | CN1300222A Strategically modified hepatitis b core proteins and their derivatives |
| 06/20/2001 | CN1299973A HCV-free-blood external preparing method |
| 06/20/2001 | CN1299833A Human vessel endothelium growth factor resisting single stranded antibody and its preparation |
| 06/19/2001 | US6248872 Nucleotide sequences which code enzymatic protein; for use in detection and treatment of dirofilaria infection |
| 06/19/2001 | US6248864 Compounds and methods and modulating tissue permeability |
| 06/19/2001 | US6248863 Phoh homolog |
| 06/19/2001 | US6248721 Method of using mouse model for evaluation of HIV vaccines |
| 06/19/2001 | US6248712 Urokinase-type plasminogen activator receptor |
| 06/19/2001 | US6248594 Kinesin-like motor protein |
| 06/19/2001 | US6248585 Haptenized tumor cells and cell culture medium containing a concentration of human serum albumin; increased storage stability |
| 06/19/2001 | US6248583 Chromosomally-encoded membrane protein of borrelia burgdorferi |
| 06/19/2001 | US6248582 Gene deleted recombinant FeLV proviral DNA for production of vaccines against FeLV |
| 06/19/2001 | US6248581 Mycobacteria functional screening and/or expression vectors |
| 06/19/2001 | US6248578 Infectious clone for human parainfluenza virus type 3 |
| 06/19/2001 | US6248576 Histidinol dehydrogenase |
| 06/19/2001 | US6248574 Fusion protein of polypeptide derived from gp41 or gp120 of defined amino acid sequence and a non-human immunodeficiency virus polypeptide sequence; diagnosis; immunotherapy; immunotoxins; vaccines |
| 06/19/2001 | US6248565 Immunization with plasmid encoding immunogenic proteins and intracellular targeting sequences |
| 06/19/2001 | US6248563 Chlamydia trachomatis serotype D genes |
| 06/19/2001 | US6248562 Chimeric proteins comprising borrelia polypeptides and uses therefor |
| 06/19/2001 | US6248557 RatC |
| 06/19/2001 | US6248556 Nucleotide sequence of guanosine triphosphate-binding protein from staphylococcus; diagnosis of infections; drug screening; bactericides; bacteriostats; vaccines; probes; primers; vectors; host cells |
| 06/19/2001 | US6248555 Nucleotide and amino acid sequence of mutant presenilin 1; diagnosis; screening; drug screening; probes; primers; host cells; vectors |
| 06/19/2001 | US6248554 DNA sequence coding for a BMP receptor |
| 06/19/2001 | US6248551 Helicobacter aliphatic amidase AmiE polypeptides, and DNA sequences encoding those polypeptides |
| 06/19/2001 | US6248546 Assay of IGFBP complex |
| 06/19/2001 | US6248538 Kit for detecting antibodies against preferential bacteria; for the detection of lyme disease |
| 06/19/2001 | US6248532 Detecting modulators of regulatory element; incubate nucleotide sequences with modulators, monitor binding to nucleotide sequences, comparing binding in the presence and absence modulators |
| 06/19/2001 | US6248517 Amino acid sequences; diagnosis of lyme disease; recombinant production; vaccines |
| 06/19/2001 | US6248516 Library for expression of immunoglobulin heavy chain variable domains |
| 06/19/2001 | US6248513 In vitro detection of infection of cells by microorganism; incubate immunoglobulins with cells and detect the formation of protein immunoglobulin complexes |
| 06/19/2001 | US6248334 Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this process |
| 06/19/2001 | US6248333 Nucleic acids |
| 06/19/2001 | US6248332 Targeted immunostimulation with bispecific reagents |
| 06/19/2001 | US6248330 Genetic engineering; polypeptides |
| 06/19/2001 | US6248329 Parasitic helminth cuticlin nucleic acid molecules and uses thereof |
| 06/19/2001 | US6248328 HIV-1 virus isolates of a subtype and its differential diagnostics, a vaccine against HIV-1 virus infections of this subtype and method of producing same, use of the HIV-1 virus isolates |